Transpacific TAVR Registry

Part of paid clinical trials in Stanford, California.

Sponsor
Duk-Woo Park, MD
Study ID
NCT03826264
Status
Recruiting
Apply to this trial

Conditions

  • Aortic Valve Insufficiency
  • Heart Valve Diseases

Eligibility Criteria

Sex
ALL
Age
19 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • TAVR — PROCEDURE
    transcatheter aortic valve replacement (TAVR)

Study Details

This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.

Key Dates

First listed
Feb 1, 2019
Start date
Jun 15, 2019
Status verified
Dec 2025
Primary completion
Dec 31, 2035
Completion
Dec 31, 2036

Study Design

Enrollment
10,000 participants (estimated)

Arms

  • Arm: Korea Centers
    Seoul, Korea All Patients undergoing TAVR
  • Arm: Stanford University
    California, USA All Patients undergoing TAVR
  • Arm: Northwestern University
    Evanston, Illinois, USA All Patients undergoing TAVR
  • Arm: Cheng-Hsin Hospital
    Taipei, Taiwan All Patients undergoing TAVR

Primary Outcome Measure

Event rate of all cause death [ Time Frame: 1 year ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Stanford UniversityStanfordCalifornia94305
Alan Ching Yuen Yeung, MD
Alan Ching Yuenn Yeung, MD (PRINCIPAL_INVESTIGATOR)
Northwestern Memorial HospitalChicagoIllinois60611
James D. Flaherty, MD
James D. Flaherty, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Stanford, CA

By research site
Stanford University· Stanford, CANorthwestern Memorial Hospital· Chicago, IL

Related Studies